# A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

> **NCT02682927** · PHASE3 · COMPLETED · sponsor: **Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.** · enrollment: 262 (actual)

## Conditions studied

- Dravet Syndrome
- Seizure Disorder

## Interventions

- **DRUG:** ZX008 (Fenfluramine Hydrochloride)
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT02682927
- **Lead sponsor:** Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-15
- **Primary completion:** 2020-07-29
- **Final completion:** 2020-07-29
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682927, "A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02682927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*